Zinc supplemnt in premenstruation syndrome

Phase 2

• Conditions: Premenstrual tension syndrome.; Premenstrual tension syndrome; N94.3

• Registration Number: IRCT20221127056632N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

Age between 20-35 years
History of regular menses at least in the last 6 months (each cycle lasts 21-35 days and the amount of bleeding is not severe and has less than 7 days of bleeding)
Body mass index between 19.8 and 26
Diagnosis of premenstrual syndrome based on PSST questionnaire

Exclusion Criteria

Any chronic illness or psychiatric illness caused by severe PMS
Receiving hormonal psychiatric drugs, supplements at the time of the study or 6 months before
Smokers and vegetarians
Suspected pregnancy, desire to become pregnant, current breastfeeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Physical and psychological symptoms of premenstrual syndrome. Timepoint: At the beginning of the study (when sampling and before the start of the intervention) and 3 months after the start of the intervention. Method of measurement: Premenstrual Symptoms Screening Tool questionaire.